279 results on '"Atay, Scott"'
Search Results
2. Surgical decision-making in advanced-stage non–small cell lung cancer is influenced by more than just guidelines
3. Alternative discharge destination following lobectomy: Analysis of a national quality improvement database
4. Initial management and outcomes of nonmalignant esophageal perforations: A Nationwide Inpatient Sample analysis
5. Centers for Disease Control (CDC) Wound Classification is Prognostic of 30-Day Readmission Following Surgery
6. Early outcomes of lung transplantation with lung allografts from coronavirus disease 2019 (COVID-19)–positive donors
7. Longer hospitalizations, more complications, and greater readmissions for patients with comorbid psychiatric disorders undergoing pulmonary lobectomy
8. Association between underweight status and chylothorax after esophagectomy for esophageal cancer: A propensity score–matched analysis
9. Living on the edge: Role of adjuvant therapy after resection of primary lung cancer within 2 millimeters of a T-stage cutoff
10. Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial
11. Outcomes of single-lung retransplantation after double-lung transplantation
12. Optimizing the prelung transplant candidate
13. Delays to surgery and worse outcomes: The compounding effects of social determinants of health in non–small cell lung cancer
14. Estimating revenue, costs, and operating margin of any hospital-based thoracic surgery practice using a novel financial model
15. Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non–small cell lung cancer with positive surgical margins
16. Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non–small cell lung cancer tumors
17. Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer
18. Ethical Concerns Regarding the Timing of Written Consent.
19. Regional Variation in Treatment for Highest-Risk Patients With Non-Small Cell Lung Cancer
20. Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and Resection
21. Exploring the Potential Different Outcomes Associated With the Different Phenotypes Under the Shared Pathologic T3N0 Designation
22. Enhanced Recovery After Surgery Protocol Minimizes Intensive Care Unit Utilization and Improves Outcomes Following Pulmonary Resection
23. Gender representation among leadership at national and regional cardiothoracic surgery organizational annual meetings
24. Understanding thoracic surgeons' perceptions of administrative database analyses and guidelines in clinical decision-making
25. A systematic review of paraneoplastic syndromes associated with thymoma: Treatment modalities, recurrence, and outcomes in resected cases
26. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer
27. Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non–Small Cell Lung Cancer
28. The Effect of Socioeconomic Status on Treatment and Mortality in Non-Small Cell Lung Cancer Patients
29. Stereotactic body radiation therapy for early-stage non-small cell lung cancer in the USA: patterns of adoption and potential healthcare disparities
30. Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus
31. A Modern Reaffirmation of Surgery as the Optimal Treatment for Solitary Fibrous Tumors of the Pleura
32. A Painless Right Anterior Neck Mass
33. Delayed esophagectomy for adenocarcinoma is associated with a negative impact on long‐term survival and an increased risk of perioperative morbidity
34. Optimizing the prelung transplant candidate
35. Early outcomes of lung transplantation with lung allografts from COVID-19-positive donors
36. Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel
37. Delayed esophagectomy for adenocarcinoma is associated with a negative impact on long‐term survival and an increased risk of perioperative morbidity.
38. Fluctuations in Spinal Cord Perfusion Pressure: A Harbinger of Delayed Paraplegia After Thoracoabdominal Aortic Repair
39. Longer Hospitalizations, More Complications, and Greater Readmissions for Patients with Comorbid Psychiatric Disorders Undergoing Pulmonary Lobectomy
40. Supplementary Figure S5 from Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells
41. Supplementary Table S1 from Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells
42. Supplementary Methods from Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells
43. Supplementary Table 2 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
44. Supplementary Table 3 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
45. Supplementary Figure 4 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
46. Data from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
47. Supplementary Figure 3 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
48. Supplementary Table 1 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
49. Supplementary Figure 2 from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
50. Supplementary Methods from Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.